Neurostimulation Devices provides much needed therapeutic relief to an unprecedented number of people affected by debilitating neurologic and psychiatric disorders worldwide. In addition, Neurostimulation therapies include invasive and noninvasive approaches that apply electromagnetic energy to speciﬁc anatomical targets to induce neuromodulation of the corresponding neural circuitry. In particular, invasive neurostimulation therapies have emerged as an effective treatment for a growing number of medically resistant neurologic and neuropsychiatric disorders.
The Global Neurostimulation Devices Market was valued at $ XX Mn in 2018 and is forecast to grow at a XX% CAGR between 2018 and 2026, resulting in 2026 global sales of $ XX. The market is driven by owing increasing prevalence of neurological disorders to drive the market growth. However, the absence of skilled professionals expected to restrain market growth. Moreover, expansion in emerging economies is providing ample opportunities for the market.
Neurostimulation Devices depending on technology, Spinal Cord Stimulation (SCS) segment is expected to account for the largest share of the Neurostimulation Devices market due to SCS is utilized in neurological problems, such as neuritis, complex regional pain syndrome, neuropathy, failed-back surgery syndrome, arachnoiditis and nerve damage.
The Global Neurostimulation Devices market is segmented on the basis of technology application and region.
Based on the Technology: External Neuromodulation (Non-Invasive), and Internal Neuromodulation.
Based on Application: Pain Management, Dystonia, Depression, Epilepsy, Parkinson's disease, and Other Applications.
Based on Region: North America, Asia-Pacific, Europe, and LAMEA. Among that North America held the largest share of the market due to couple with the rising funds in the country for the implementation of cutting-edge technology enormous biopharmaceutical industries and pharmaceutical is anticipated to drive the regional growth of the market over the estimated period. Moreover, the growing concern about the prevalence of associated disorders and other neurological disorder is stimulating the need for the acceptance of neuromodulation techniques.
The report covers in-depth analysis of Global Neurostimulation Devices Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by Technology (External Neuromodulation (Non-Invasive), and Internal Neuromodulation.). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in the Global Neurostimulation Devices Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.